Dx assays pte ltd was established in 2008 and is the first commercial developer of molecular diagnostic assays in Singapore.
We specialize in Nucleic Acid-based Test (NAT) Development and offer highly customizable services with no restriction to any particular chemistry or instrumentation platform. Our client requirements in areas such as infectious diseases, oncology, genetic testing and companion diagnostics becomes the in-put for our team of scientists to customize our service package to fulfil all your business needs.
Our key services can be divided into 5 major areas:
• MOLECULAR DIAGNOSTICS
• PRODUCT ENHANCEMENT SERVICES
• VERIFICATION & VALIDATION
• COMPANION DIAGNOSTICS
• LABORATORY DEVELOPED TESTS
Company Details
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- dxassays.com
Dx Assays Pte. Ltd. Questions
Dx Assays Pte. Ltd.'s website is dxassays.com
Dx Assays Pte. Ltd.'s LinkedIn profile is https://www.linkedin.com/company/dx-assays-pte.-ltd.
Dx Assays Pte. Ltd.'s industry is
Biotechnology Research
Dx Assays Pte. Ltd.'s top competitors are
Wisdommedicalsupplies,
Oncolille,
Kimera Health,
Createlab,
Ionic Transport Assays,
Zeno Therapeutics Pte. Ltd.,
United Immunoassay,
National Cancer Centre Singapore,
Bioacumen Global Pte Ltd,
Abasia Biolabs.
Dx Assays Pte. Ltd.'s categories are Biotechnology Research
Dx Assays Pte. Ltd.'s founding year is 2007
